Posters | 14 10 2015

EDRS

Cognitive enhancing drug use among regular psychostimulant users

Overview

 

Cognitive enhancing drugs (CEs; also called ‘smart drugs’, ‘study drugs’, or ‘nootropics’) have the potential to improve intellectual abilities in healthy individuals. While students’ CE use has attracted public interest, few Australian studies exist1. The effectiveness of CEs and the prevalence of use remains unclear2,3.

 

CE use has been associated with illicit drug use and risky drug behaviours4.We examined the prevalence and predictors of recent (preceding 6 months) CE use and associated negative side effects among regular psychostimulant users (RPU) from the national 2015 EDRS sample.